REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
17/10/2025
Voltar para busca
Dado oficial do USPTO
TARGET HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
TARGET HEALTH
ST13
US500000078313401Classe
35, 41, 42, 44
Pedido
78313401
Registro
3156025
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
18/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 44
Data de depósito
14/10/2003
Data de registro
17/10/2006
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/01/2017
Última transação
18/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
1993-00-00
Primeiro uso no comércio
1993-00-00
Código do desenho
1
Tipo de titular
16
Localização do titular
NEW YORK, NY
Examinador
KAZAZIAN,MICHAEL H
Unidade examinadora
M40
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
TARGET HEALTH, LLC
Target Health, Inc.
Representantes
Kenneth I. Kohn KOHN & ASSOCIATES, PLLC
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business auditing servicesperforming pre-inspection goods manufacturing practices audits and assuring that user fee monies are submitted; biostatistics and data processing services; providing statistical information; performing statistical analyses; manufacturer representatives in the field of pharmaceuticals
Classe 41
Computer servicesproviding online journals in fields of health and medicine
Classe 42
Providing quality assurance services in the field of pharmaceuticals; reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; consulting services regarding food and drug law and regulation compliancepreparing for and conducting meetings to discuss and negotiate development strategiespreparing and submitting documents and forms required by the FDApreparing responses to FDA questions and warning lettersfollow-up with FDA on post application submission questionspreparing for and conducting meetings with legal counseltroubleshooting product and process issuesperforming analytical methods development and validationdesigning and implementing safety and regulatory toxicology programs; intellectual property licensing in the fields of drugdrug productpharmaceutical and pharmaceutical products; medical and scientific researchconducting clinical trialsspecifically preparing protocolscase report forms and informed consent formsperforming qualificationinitiationmonitoring and closeout visitsgenerating investigator study filesmonitor drug supplyidentifying study sites and managing investigator paymentspreparing clinical sites for FDA inspection; consultation in the fields of drug developmentincluding working with sponsormedicalscientifictoxicologymanufacturing and business experts to clearly delineate development requirementsevaluating available and competitive technologies; product and process development services; technical writing for othersspecificallyintegrated clinical and statistical study reports and other regulatory manuscripts
Classe 44
Providing an on-line database for use in gathering and providing patient records and patient data via a global computer network
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/08/2020
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
14/01/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
14/01/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
14/01/2017
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
12/01/2017
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
11/05/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
12/09/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/09/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2012
E815
TEAS SECTION 8 & 15 RECEIVED
20/08/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
17/10/2006
PUBO
PUBLISHED FOR OPPOSITION
25/07/2006
NPUB
NOTICE OF PUBLICATION
05/07/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2006
ALIE
ASSIGNED TO LIE
31/05/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/05/2006
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
15/11/2005
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/05/2005
CNSL
LETTER OF SUSPENSION MAILED
08/11/2004
CNSL
SUSPENSION LETTER WRITTEN
08/11/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/11/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/10/2004
PAPER RECEIVED
20/10/2004
CNRT
NON-FINAL ACTION MAILED
11/05/2004
DOCK
ASSIGNED TO EXAMINER
26/04/2004
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace TARGET HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.